These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3873228)

  • 1. Cefoxitin resistance in community-acquired gram-negative bacillary bacteremia. Associated clinical risk factors.
    McCue JD
    Arch Intern Med; 1985 May; 145(5):834-6. PubMed ID: 3873228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prior antimicrobial drug exposure: a risk factor for trimethoprim-sulfamethoxazole-resistant urinary tract infections.
    Metlay JP; Strom BL; Asch DA
    J Antimicrob Chemother; 2003 Apr; 51(4):963-70. PubMed ID: 12654756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of trimethoprim/sulfamethoxazole as prophylactic therapy of gram-negative sepsis in pediatric patients with cancer.
    Esquembre C; Ferris J; Verdeguer A; Castel V
    Pediatrics; 1986 Oct; 78(4):719-20. PubMed ID: 3489920
    [No Abstract]   [Full Text] [Related]  

  • 4. Predictive model of antimicrobial-resistant gram-negative bacteremia at the ED.
    Chiang WC; Chen SY; Chien KL; Wu GH; Yen AM; Su CP; Lee CC; Chen YC; Chang SC; Chen SC; Chen WJ; Chen TH
    Am J Emerg Med; 2007 Jul; 25(6):597-607. PubMed ID: 17606081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibiotic resistance of Escherichia coli. Importance of the resistance to trimethoprim-sulfamethoxazole].
    Riou B; Richard C; Rimailho A; Coquin Y; Rottman E; Auzepy P
    Ann Med Interne (Paris); 1985; 136(5):412-5. PubMed ID: 3904566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Antananarivo, Madagascar.
    Randrianirina F; Soares JL; Carod JF; Ratsima E; Thonnier V; Combe P; Grosjean P; Talarmin A
    J Antimicrob Chemother; 2007 Feb; 59(2):309-12. PubMed ID: 17138569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Urinary infection. I. Comparative in vitro activities of several antibiotic drugs against Gram-negative bacteria].
    Giachino F; Allocco A; Tuninetti L; Tullio V; Cuffini AM; Carlone NA
    G Batteriol Virol Immunol; 1992 Jan-1993 Dec; 85(1-12):55-67. PubMed ID: 7498617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for resistance to "first-line" antimicrobials among urinary tract isolates of Escherichia coli in children.
    Allen UD; MacDonald N; Fuite L; Chan F; Stephens D
    CMAJ; 1999 May; 160(10):1436-40. PubMed ID: 10352632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiology of community-acquired bacterial pneumonia in persons with and at risk for human immunodeficiency virus type 1 infection. Implications for rational empiric antibiotic therapy.
    Burack JH; Hahn JA; Saint-Maurice D; Jacobson MA
    Arch Intern Med; 1994 Nov; 154(22):2589-96. PubMed ID: 7979856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: a retrospective case series.
    Pastewski AA; Caruso P; Parris AR; Dizon R; Kopec R; Sharma S; Mayer S; Ghitan M; Chapnick EK
    Ann Pharmacother; 2008 Sep; 42(9):1177-87. PubMed ID: 18664609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon.
    Piéboji JG; Koulla-Shiro S; Ngassam P; Adiogo D; Njine T; Ndumbe P
    Int J Infect Dis; 2004 May; 8(3):147-54. PubMed ID: 15109589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary tract infection. Diabetics and non-diabetic patients.
    Akbar DH
    Saudi Med J; 2001 Apr; 22(4):326-9. PubMed ID: 11331489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of therapy with cefoxitin.
    McCloskey RV; Goren RC
    Clin Ther; 1980; 3(2):66-79. PubMed ID: 7448845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteremias due to Citrobacter diversus and Citrobacter freundii. Incidence, risk factors, and clinical outcome.
    Drelichman V; Band JD
    Arch Intern Med; 1985 Oct; 145(10):1808-10. PubMed ID: 3899035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous sulfamethoxazole and trimethoprim for serious gram-negative bacillary infection.
    Sattler FR; Remington JS
    Arch Intern Med; 1983 Sep; 143(9):1709-12. PubMed ID: 6615092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gentamicin resistance among gram-negative bacillary blood isolates in a hospital with long-term use of gentamicin.
    Mylotte JM
    Arch Intern Med; 1987 Sep; 147(9):1642-4. PubMed ID: 3307673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.
    Brown PD; Freeman A; Foxman B
    Clin Infect Dis; 2002 Apr; 34(8):1061-6. PubMed ID: 11914994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive care unit-acquired urinary tract infections in patients admitted with sepsis: etiology, risk factors, and patterns of antimicrobial resistance.
    Mojtahedzadeh M; Panahi Y; Fazeli MR; Najafi A; Pazouki M; Navehsi BM; Bazzaz A; Naghizadeh MM; Beiraghdar F
    Int J Infect Dis; 2008 May; 12(3):312-8. PubMed ID: 18032082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-acquired MRSA infections in North Carolina children: prevalence, antibiotic sensitivities, and risk factors.
    Shapiro A; Raman S; Johnson M; Piehl M
    N C Med J; 2009; 70(2):102-7. PubMed ID: 19489364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.